摘要
目的:分析《中国药品标准》创刊22年来的刊发论文的文献计量学数据特征。方法:基于CNKI数据库检索《中国药品标准》2000—2021年刊出文献,导出全部调研项目,对非论文条目全部手工剔除,然后进行统计分析。采用VOSviewer软件进行作者合作和关键词共现分析。结果:22年间《中国药品标准》共发表论文2599篇,总被引频次为8998次,总下载量为442043次,基金项目资助论文191篇,近5年基金项目资助论文为130篇,年度发文量呈现近似N型曲线。初步形成了核心作者、团队和机构群;报道重点为中药、化学药和生物制品的质量标准研究等方面内容。结论:22年来,《中国药品标准》的文献计量学数据不断增长,期刊质量和影响力持续提升,反映了我国药品标准体系建设取得的成就,促进了国家药品标准事业的发展。
Objective:To analyze the bibliometric characteristics of papers published in Drug Standards of China in the past 22 years.Methods:The documents published in Drug Standards of China from 2000 to 2021 were searched based on CNKI database.All research projects were exported,and the non-paper items were manually eliminated.Then the statistical analysiswasperformed.Vosviewer was used for author cooperation and keyword co-occurrence analysis.Results:Over the 22 years,there have been 2599 papers published in Drug Standards of China,with a total of 8998 citations and 442043 downloads.And there have been 191 papers with fund project,and 130 papers with fund project in recent 5 years.The annual publications present an approximately N-shaped distribution.The core author teams and institutions were initially formed.Research on the quality standards of traditional Chinese medicine,chemical drug and biological product was focally reported.Conclusion:In the past 22 years,the bibliometric data of Drug Standards of China have been increasing,and the quality and influence of journals have been continuously improved.It has reflected the achievements made in the construction of Chinese drug standard system,and promoted the development of Chinese drug standard.
作者
徐连敏
XU Lianmin(Chinese Pharmacopoeia Commission,Beijing 100061,China)
出处
《中国药品标准》
CAS
2022年第3期316-321,共6页
Drug Standards of China
关键词
《中国药品标准》
文献计量学
科技期刊
分析
Drug Standards of China
bibliometrics
scientific and technological journals
analysis
